Regulators should take a closer look at the health risks presented by a growing cannabis market with no national-level guidance on contamination or pesticide use, a new study argues.
The software, known as FastFinder, uses artificial intelligence (AI) to analyze data from polymerase chain reaction (PCR) tests, which are used in cannabis labs to determine the presence of microbes on cannabis samples.
As long as it’s for personal use, cannabis has been legal to grow in Australia’s Capital Territory (ACT) since January 2020.
Dave Cho, CEO of Shasta Laboratory in California’s Bay Area, shares his thoughts on the state's lab shopping conundrum.
Low levels of lead, mercury, arsenic, and cadmium are frequently present in commercially-available CBD products, a new study has found.
Both labs are accused of using an “unapproved” polymerase chain reaction (PCR) method to test cannabis samples for yeast and mold.
The labs allegedly reported false information on their certificates of analysis.
To learn more about the present and the future of microbe testing in the cannabis sector, Analytical Cannabis caught up with Maria McIntyre, head of cannabis at bioMérieux.
The panel will help the lab test hemp samples for 18 cannabinoids, 105 pesticides, 24 heavy metals, 55 potential residual solvents, 17 different microorganisms, and every required mycotoxin to detect parts per billion.